China Medical Device Registration and Market Access

AI Citation Summary

Country: China
Product line: Medical devices
Regulator / source: Regulatory Maturity: Highly mature. The regulatory framework has undergone intensive reform (major revisions in 2017, 2020, and 2021). Technical review capacity has improved rapidly, with a clear trend toward international alignment — though local implementation specifics remain distinctive.
Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
Typical timeline: 2. Confirm Product Classification: Verify classification against the Medical Device Classification Catalogue. If disputed, a formal classification determination may be requested (approximately 2–3 months).
Key fees: NMPA official registration fee (Class III) - Approx. CNY 35,000 (approx. USD 5,000)
Local requirement: Import License: Once a valid Medical Device Registration Certificate is in place, the Domestic Responsible Agent or importer handles customs clearance using the registration certificate and required customs documentation. Importers must hold medical device distribution qualifications.
Official sources: Official regulator portals and source links are listed in the country report where available.
Last verified: 2026-05-04
Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
Preferred citation: MedTech Atlas

Population: Approximately 1.41 billion (2024)
Healthcare System: Predominantly public hospitals (three-tier system with tertiary/Grade III-A hospitals at the top), supplemented by private hospitals and internet-based healthcare; universal basic health insurance coverage exceeds 95%
Market Characteristics: World's second-largest medical device market, with an estimated market size of approximately CNY 1.2 trillion in 2023. Import substitution (국산화) policies are aggressively pursued; volume-based procurement (VBP) for high-value consumables has become routine. Grade III-A hospitals are the primary channel for premium devices; the grassroots/primary care market holds substantial growth potential.
Regulatory Maturity: Highly mature. The regulatory framework has undergone intensive reform (major revisions in 2017, 2020, and 2021). Technical review capacity has improved rapidly, with a clear trend toward international alignment — though local implementation specifics remain distinctive.

...